<DOC>
	<DOCNO>NCT02773147</DOCNO>
	<brief_summary>The purpose study investigate B vitamin substitution effect NFL ( neurofilament light protein ) plasma level neurocognitive performance HIV-infected individual increase plasma homocysteine</brief_summary>
	<brief_title>Effect Vitamin B Plasma Neurofilament Light Protein ( NFL ) HIV-infected Individuals With Increased Plasma Homocysteine</brief_title>
	<detailed_description />
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<criteria>1 . The ability understand give inform consent participate . 2 . HIV1 infect stable ART &gt; 12 month 3 . Plasma HIVRNA &lt; 50 copies/ml 4 . Plasma homocysteine ≥ 12 μmol/L ( subject &lt; 12 μmol/L include analysis secondary endpoint 3 ( see 5.4 ) . 5 . Male female , age 18 old . 1 . Treatment trimethoprimsulfamethoxazole methotrexate 2 . Ongoing B6 , B12 folate substitution 3 . Antiepileptic treatment 4 . Small bowel ventricular resection 5 . Disturbed absorption small bowel ( Mb Crohn , untreated coeliac disease ) 6 . Ongoing neurological disease severe psychiatric disease 7 . Any malignant tumor history . 8 . Severe ongoing infection opportunistic infection 9 . AUDIT &gt; 7 men &gt; 5 woman 10 . MADRS &gt; 20 11 . Significant B12 folate deficiency indicate substitution ( subject offer adequate substitution , include analysis secondary endpoint 3 ( see 5.4 ) ) . 12 . Pregnancy screen visit , plan pregnancy study period exclusion criterion . ( Not due toxicity Triobe , elevate risk prescribed Bvitamins outside trial . If study object get pregnant study , continue study must exclude start treatment Bvitamin treatment Triobe . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>